These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36641977)

  • 1. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
    Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
    Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.
    Chen CY; Zhang W; Xu XR; Pu YT; Tu YD; Peng W; Yao X; Zhou S; Fang BJ
    Chin J Integr Med; 2024 Feb; 30(2):107-114. PubMed ID: 37222827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study.
    Lu Y; Zhang M; Yang QQ; Li WJ; Yang K; Hu W; Gao SY; Jiang QL; Lin LK; Cheng H; Sun F
    Evid Based Complement Alternat Med; 2023; 2023():6028554. PubMed ID: 36846053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial.
    Xu X; Zhou S; Chen C; Li J; Wu H; Jin G; Zhou J; Wang G; Cao M; Sun D; Zhang W; Peng W; Pu Y; Sun Y; Fang B; Xu J
    Phytomedicine; 2023 Jan; 108():154514. PubMed ID: 36334390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.
    Qiao Y; Xu X; Zhou F; Wang K; Li M; Liu C; Chen Z; Yin P; Shi Y; Wang Y; Liu Q
    Phytomedicine; 2023 Apr; 112():154690. PubMed ID: 36780823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
    Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
    Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Lianhua Qingwen Granule and Jingyin Gubiao Prescription in Omicron BA.2 Infection and Hospitalization: A Real-World Study of 56,244 Cases in Shanghai, China.
    Zhang YJ; Liu GJ; Zhang H; Liu C; Chen ZQ; Xian JS; Song DL; Liu Z; Yang X; Wang J; Zhang Z; Zhang LY; Feng H; Zhang YQ; Tan L
    Chin J Integr Med; 2024 Jun; ():. PubMed ID: 38910189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
    Zhan YQ; Chen RF; Zheng QS; Li XW; Liu YN; Mootsikapun P; Chayakulkeeree M; Arttawejkul P; Lan TTN; Liu GG; Lu HZ; Liu QQ; Zhong NS; Yang ZF; Zheng JP
    J Thorac Dis; 2023 May; 15(5):2859-2872. PubMed ID: 37324081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of children with Omicron variant infection in Chengdu area, China].
    Jiang J; Yang M; Li DY; Qiao LN; Zhang HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):849-854. PubMed ID: 37668034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
    Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
    Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
    Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Nasal Irrigation in Children With Omicron Variant of COVID-19 Infection.
    Liu L; Wang C; Xie S; Su L; Wang C
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):54S-59S. PubMed ID: 37329222
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study.
    Kapar A; Xie S; Guo Z; Nan Y; Du Y; Yin X; Gong T; Gu X; Zhou Y; Lu W; Yang A; Luo Z; Dai J; Wang K; Zhao S; Wang K
    Expert Rev Anti Infect Ther; 2024 Jul; 22(7):569-577. PubMed ID: 38822541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of children and their family members with family clusters of SARS-CoV-2 Omicron variant infection in Shanghai, China: an analysis of 380 cases].
    Bian XL; Guo Z; Zhang K; Li MC; Wu ZM; Jiang Q; Guo MM; Fan SN; Chen JJ; Hui L; Zheng F; Zhang JP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1085-1091. PubMed ID: 36305107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
    Hong L; He M; Li S; Zhao J
    Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel coronavirus infections in Shanghai].
    Xu X; Sun D; Cao M; Zhang W; Pu Y; Chen C; Sun Y; Zhou S; Fang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):449-453. PubMed ID: 35728842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
    Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
    J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, open-label, randomized controlled trial.
    Yu Z; Zheng Y; Chen B; Lv J; Zhu X; Shang B; Xv Y; Tao R; Yang Y; Cong J; Li D; Wu H; Qv W; Zhang X; Xv C; Feng H; Yuan W; Gao Y
    Phytomedicine; 2023 Nov; 120():155025. PubMed ID: 37639813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and Mortality of Hospital-Onset SARS-CoV-2 Infections Due to Omicron Versus Prior Variants : A Propensity-Matched Analysis.
    Klompas M; McKenna CS; Kanjilal S; Pak T; Rhee C; Chen T
    Ann Intern Med; 2024 Aug; 177(8):1078-1088. PubMed ID: 39008853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of severe acute respiratory syndrome coronavirus 2 Omicron variant infection in children: an analysis of 201 cases].
    Zhang YF; Liang SS; Wu PL; Cai YL; Lin YL; Wang QW; Zhuang XB; Chen SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):5-10. PubMed ID: 36655657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.